Drug Type Therapeutic vaccine |
Synonyms DNAJB1-PRKACA Fusion Transcript-based Peptide(University Hospital Tuebingen), Fusion Transcript-based Peptide Vaccine(University Hospital Tuebingen), FusionVAC-XS15 |
Target- |
Action stimulants |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Fibrolamellar Hepatocellular Carcinoma | Phase 1 | Germany | 26 Sep 2023 |